RELMADA THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
RELMADA THERAPEUTICS, INC. (RLMD) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $2.72 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-03-19
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $2.72M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $1.55M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $3.77M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $13.78M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Deferred Tax Assets, Operating Loss Carryforwards, State and Local as first filed |
|---|---|---|
| 2025-12-31 | $2.72M 10-K · filed 2026-03-19 | |
| 2024-12-31 | $1.55M 10-K · filed 2026-03-19 | |
| 2023-12-31 | $3.77M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $13.78M 10-K · filed 2024-03-19 | |
| 2021-12-31 | $12.51M 10-K · filed 2023-03-23 | |
| 2020-12-31 | $9.36M 10-K · filed 2022-03-25 | |
| 2019-12-31 | $7.91M 10-K · filed 2021-03-24 | |
| 2019-06-30 | $8.25M 10-K · filed 2021-03-24 | |
| 2018-06-30 | $6.68M 10-KT · filed 2020-03-26 | $2.96M 10-K · filed 2018-09-28 |
| 2017-06-30 | $2.54M 10-K · filed 2018-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |